- In recent days, Arm Holdings reported solid momentum in AI-related licenses and royalties while announcing a shift to manufacturing its own CPUs, just as easing geopolitical tensions and improving macro signals increased demand expectations for AI infrastructure across global markets.
- The combination of expanding AI partnerships, a broader role in the CPU value chain, and a more supportive risk background has increased investor attention to how AI workloads and custom silicon can reshape Arm’s long-term business mix and revenue drivers.
- Here we consider how Arm’s decision to manufacture CPUs as AI infrastructure demands grow could impact the company’s existing investment story.
AI is changing healthcare. These 38 stocks address everything from early diagnosis to drug discovery. The best part is that these companies have market capitalizations of less than $10 billion. There’s still time to get in early.
Arm Holdings Investment Story Summary
To own Arm today, you need to believe that its shift from pure IP licensing to data center and AI silicon can support profitable growth without compromising its high-margin royalty base. While the recent surge in AI-related licenses, royalties, and CPU manufacturing plans strengthens the short-term push for AI data center adoption, it also increases the biggest risk: major failures in R&D and execution could weigh on margins if new products fail to scale as expected.
Among recent announcements, the launch of Arm AGI CPUs stands out as the most relevant. With committed customer demand exceeding USD 2 billion in 2027 and 2028 and partners like Meta, the transition to production silicon is directly related to increased AI infrastructure spending. While this strengthens Arm’s AI data center catalyst, it also increases the risk of execution risk as the company moves deeper into the CPU value chain and competes more directly with incumbent chipmakers.
However, investors should be aware that behind the enthusiasm for AI workloads, competition from alternative architectures and open standards may increase.
Read the full story about Arm Holdings (it’s free!)
The Arm Holdings story projects sales of $9.5 billion and profits of $2.9 billion by 2029. This would require annual sales growth of 26.8% and an increase in profits of approximately $2.1 billion from the current $801 million.
Reveals how Arm Holdings’ forecasts generate a fair value of $171.98, 51% lower than the current price.
explore other perspectives
While the consensus story relies on steady adoption of AI, the most optimistic analysts are already modeling 2029 sales of about $11.5 billion and revenue of $3.8 billion, assuming Arm overcomes the rise in open standards and RISC V competition. This shows how differently you and other investors can interpret the same AI news stream, and how those views may still change after Arm’s latest CPU manufacturing push.
Check out 16 other fair value estimates for Arm Holdings – why the stock could be worth less than half its current price!
decide for yourself
Don’t just follow the ticker, dig deep into the data and truly build your own beliefs.
Need an alternative?
Don’t miss your chance to be the next 10 bagger. Latest stocks fell:
- Take advantage of the AI infrastructure supercycle with our “handpicked selection” of the 47 best AI gold rushes that transform record demand into massive cash flows.
- Discover the 29 top quantum computing companies leading the revolution in next-generation technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- Rare earth metals are raw materials for most high-tech equipment, military and defense systems, and electric vehicles. Global competition continues to secure supplies of these critical minerals. Beat the pack to find the best 31 rare earth metal stocks among the few rare earth metal stocks that mine this important strategic resource.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
new: Manage all your stock portfolios in one place
What we created is The ultimate portfolio companion For stock investors, And it’s free.
• Connect an unlimited number of portfolios and see the total in one currency
• Alert you to new warning signs and risks via email or mobile phone
• Track the fair value of stocks
Try our demo portfolio for free
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.
